Implantable Cardioverter-defibrillator Utilization and Its Outcomes in Korea: Data from Korean Acute Heart Failure

Youngjin Cho1, Sang Yeong Cho1, Il Young Oh1

  • 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Insights

Implantable cardioverter-defibrillators (ICDs) are under-utilized in Korean heart failure patients with reduced ejection fraction. However, ICD use was associated with significantly lower mortality, suggesting a survival benefit in this population.

Area of Science:

  • Cardiology
  • Medical Devices
  • Public Health

Background:

  • Limited data exists on implantable cardioverter-defibrillator (ICD) utilization and benefits in Korean patients with heart failure and reduced left ventricular ejection fraction (LVEF).
  • A multicenter registry study was conducted to address this data gap.

Purpose of the Study:

  • To evaluate the utilization rate of ICDs in Korean patients with heart failure and reduced LVEF.
  • To assess the impact of ICD implantation on all-cause mortality in this patient group.

Main Methods:

  • A cohort of 485 acute heart failure patients with LVEF ≤ 35% was identified from 10 Korean tertiary hospitals.
  • ICD implantation during follow-up was assessed, and mortality was compared between ICD recipients and matched controls.

Main Results:

  • Only 11.5% of eligible patients received an ICD, indicating significant under-utilization.
  • Patients with ICDs demonstrated significantly lower all-cause mortality compared to controls (adjusted HR = 0.39; P = 0.032).
  • This survival benefit persisted after excluding patients with cardiac resynchronization therapy and was particularly notable in ischemic heart failure.

Conclusions:

  • The study highlights a substantial under-utilization of ICDs in Korean heart failure patients with reduced LVEF.
  • Findings suggest that the survival benefits of ICDs observed in clinical trials can likely be extrapolated to the Korean population.
  • Further research and clinical practice adjustments are warranted to optimize ICD use in this demographic.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
141
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
204
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
120
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
289
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
151
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
101